Y-mAbs Therapeutics, Inc. 3 SEC Filings

Filed On	Filing
17 Jan 2025	Form 3: Gentilcore Douglas J, SVP, Danyelza Bus. Unit Head No securities owned
16 Jan 2025	Form 3: LaRocca John, SVP, General Counsel & Secry
08 Jul 2024	Form 3: Pfreundschuh Peter P., CFO and Treasurer No securities owned
08 Mar 2024	Form 3: Tagliaferri Mary, Director No securities owned
08 Nov 2023	Form 3: Rossi Michael J, Director No securities owned
23 Dec 2021	Form 3: Smith Susan Laura, Senior Vice President, CCO No securities owned
18 Jun 2020	Form 3: Hamill Laura, Director No securities owned
12 Jun 2020	Form 3: Rajah Vignesh, SVP and CMO No securities owned
09 Jan 2020	Form 3: Herman Philip Karl, Sr. VP and CCO
09 Jan 2020	Form 3: Ahmed Mahiuddin, Sr. VP and CSO Holds 260,000 shares of Common Stock
19 Dec 2018	Form 3: Ber Gerard, Director
20 Sep 2018	Form 3: Tyagi Ashu, Director Holds 962,566 shares of Common Stock
20 Sep 2018	Form 3: Juan Moller San Pedro Claus, Director Holds 841,678 shares of Common Stock
20 Sep 2018	Form 3: Wg Biotech ApS, 10% owner Holds 5,010,000 shares of Common Stock
20 Sep 2018	Form 3: Wedell-Wedellsborg Johan, Director Holds 1,683,496 shares of Common Stock
20 Sep 2018	Form 3: Gad Thomas, Director Holds 1,190,000 shares of Common Stock
20 Sep 2018	Form 3: Wilms Joris, Sr. VP and COO
20 Sep 2018	Form 3: Raskin Gregory S, Director Holds 5,882 shares of Common Stock
20 Sep 2018	Form 3: Lund-Hansen Torben, Sr. VP and Head of Tech Op Holds 45,662 shares of Common Stock
20 Sep 2018	Form 3: Lisby Steen, Sr. VP and CMO

Comments